Abstract: This invention relates to antisense oligonucleotides that target mRNAs in cells as substrates for the cellular enzyme RNase H and thereby cause specific degradation of the targeted mRNA. The oligonucleotides have three components: a RNase H activating region, a complementarity region and 3' and 5' ends. The invention optimizes each of the components to resist intracellular nucleases, to increase hybridization to target mRNA, to specifically inactivate target mRNA in cells, and to decrease cytotoxicity.
Type:
Grant
Filed:
December 15, 1998
Date of Patent:
November 23, 1999
Assignees:
Oligos Etc. Inc., Tod Mitchell Woolf
Inventors:
Amy Arrow, Roderic M. K. Dale, Tod Mitchell Woolf
Abstract: This invention relates to antisense oligonucleotides that target mRNAs in cells as substrates for the cellular enzyme RNase H and thereby cause specific degradation of the targeted mRNA. The oligonucleotides have three components: a RNase H activating region, a complementarity region and 3' and 5' ends. The invention optimizes each of the components to resist intracellular nucleases, to increase hybridization to target mRNA, to specifically inactivate target mRNA in cells, and to decrease cytotoxicity.
Type:
Grant
Filed:
November 21, 1996
Date of Patent:
December 15, 1998
Assignees:
Oligos Etc. Inc., Tod Mitchell Woolf
Inventors:
Amy Arrow, Roderic M.K. Dale, Tod Mitchell Woolf